13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000905148-23-000447
Total Value
$180.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VENTYX BIOSCIENCES INC | 92332V107 | 2,298,833 | $77.0M | 42.68% |
| 2 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $43.8M | 24.30% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,035,396 | $33.8M | 18.74% |
| 4 | PHARVARIS N V | PHVS | 2,278,575 | $18.4M | 10.17% |
| 5 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,759,791 | $3.9M | 2.14% |
| 6 | ELEVATION ONCOLOGY INC | 28623U101 | 1,866,339 | $3.5M | 1.97% |